US hospitals launch non-profit generic drug producer to counter rising prices
Several American healthcare systems have joined forces to form a new non-profit pharmaceutical company to counter price gouging and scarcity of generic drugs by increasing their supply. Scott Gottlieb, the US Food and Drug Administration commissioner, has pledged to expedite approval of generic drug...
Gespeichert in:
| Veröffentlicht in: | BMJ (Online) 2018-09, Vol.362, p.k3840-k3840 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | k3840 |
|---|---|
| container_issue | |
| container_start_page | k3840 |
| container_title | BMJ (Online) |
| container_volume | 362 |
| creator | Roehr, Bob |
| description | Several American healthcare systems have joined forces to form a new non-profit pharmaceutical company to counter price gouging and scarcity of generic drugs by increasing their supply. Scott Gottlieb, the US Food and Drug Administration commissioner, has pledged to expedite approval of generic drug applications as one way to increase competition and supply, and to rein in prices. Civica Rx will initially work with generic manufacturers around the world but eventually hopes to increase production capacity within the US. |
| doi_str_mv | 10.1136/bmj.k3840 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2101270763</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2100741409</sourcerecordid><originalsourceid>FETCH-LOGICAL-b342t-696d18d2382399eee6ac988546ed928385400717805f6696b9475576b0398553</originalsourceid><addsrcrecordid>eNp10LtOwzAUBmALgWhVOvACyBIMMKQcx_FtRBU3CcRAmaPEcdqU1Cl2PPD2OLQwIDHZsj__Ov4ROiUwI4Ty63Kznr1TmcEBGhPBeEIkpYdoDIqpRBIqR2jq_RoAUiqk4uwYjSgQlQEXY_T89opXnd82fdF63BbB6hW2nU22rqubHi-NNa7RuHJhieNZFbRxuO-w7oLt49Y1vrHDVaONP0FHdcwx0_06QYu728X8IXl6uX-c3zwlJc3SPuGKV0RWKZUpVcoYwwutpGQZN5VKJY07AEGEBFbziEuVCcYEL4EqyRidoMtdbBzoIxjf55vGa9O2hTVd8HlKgKQCBKeRnv-h6y44G4cbFIiMZKCiutop7Trvnanz-J9N4T5zAvnQch5bzr9bjvZsnxjKjal-5U-nEVzswPDm_5wv_sSAyQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2100741409</pqid></control><display><type>article</type><title>US hospitals launch non-profit generic drug producer to counter rising prices</title><source>Jstor Complete Legacy</source><creator>Roehr, Bob</creator><creatorcontrib>Roehr, Bob</creatorcontrib><description>Several American healthcare systems have joined forces to form a new non-profit pharmaceutical company to counter price gouging and scarcity of generic drugs by increasing their supply. Scott Gottlieb, the US Food and Drug Administration commissioner, has pledged to expedite approval of generic drug applications as one way to increase competition and supply, and to rein in prices. Civica Rx will initially work with generic manufacturers around the world but eventually hopes to increase production capacity within the US.</description><identifier>ISSN: 0959-8138</identifier><identifier>EISSN: 1756-1833</identifier><identifier>DOI: 10.1136/bmj.k3840</identifier><identifier>PMID: 30194067</identifier><language>eng</language><publisher>England: BMJ Publishing Group LTD</publisher><subject>Corporate profits ; Generic drugs ; Gottlieb, Scott ; Liljenquist, Dan ; Nonprofit organizations ; Pharmaceutical industry ; Prices ; Shkreli, Martin</subject><ispartof>BMJ (Online), 2018-09, Vol.362, p.k3840-k3840</ispartof><rights>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to</rights><rights>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go tohttp://group.bmj.com/group/rights-licensing/permissions2018BMJ</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b342t-696d18d2382399eee6ac988546ed928385400717805f6696b9475576b0398553</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30194067$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Roehr, Bob</creatorcontrib><title>US hospitals launch non-profit generic drug producer to counter rising prices</title><title>BMJ (Online)</title><addtitle>BMJ</addtitle><description>Several American healthcare systems have joined forces to form a new non-profit pharmaceutical company to counter price gouging and scarcity of generic drugs by increasing their supply. Scott Gottlieb, the US Food and Drug Administration commissioner, has pledged to expedite approval of generic drug applications as one way to increase competition and supply, and to rein in prices. Civica Rx will initially work with generic manufacturers around the world but eventually hopes to increase production capacity within the US.</description><subject>Corporate profits</subject><subject>Generic drugs</subject><subject>Gottlieb, Scott</subject><subject>Liljenquist, Dan</subject><subject>Nonprofit organizations</subject><subject>Pharmaceutical industry</subject><subject>Prices</subject><subject>Shkreli, Martin</subject><issn>0959-8138</issn><issn>1756-1833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp10LtOwzAUBmALgWhVOvACyBIMMKQcx_FtRBU3CcRAmaPEcdqU1Cl2PPD2OLQwIDHZsj__Ov4ROiUwI4Ty63Kznr1TmcEBGhPBeEIkpYdoDIqpRBIqR2jq_RoAUiqk4uwYjSgQlQEXY_T89opXnd82fdF63BbB6hW2nU22rqubHi-NNa7RuHJhieNZFbRxuO-w7oLt49Y1vrHDVaONP0FHdcwx0_06QYu728X8IXl6uX-c3zwlJc3SPuGKV0RWKZUpVcoYwwutpGQZN5VKJY07AEGEBFbziEuVCcYEL4EqyRidoMtdbBzoIxjf55vGa9O2hTVd8HlKgKQCBKeRnv-h6y44G4cbFIiMZKCiutop7Trvnanz-J9N4T5zAvnQch5bzr9bjvZsnxjKjal-5U-nEVzswPDm_5wv_sSAyQ</recordid><startdate>20180907</startdate><enddate>20180907</enddate><creator>Roehr, Bob</creator><general>BMJ Publishing Group LTD</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20180907</creationdate><title>US hospitals launch non-profit generic drug producer to counter rising prices</title><author>Roehr, Bob</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b342t-696d18d2382399eee6ac988546ed928385400717805f6696b9475576b0398553</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Corporate profits</topic><topic>Generic drugs</topic><topic>Gottlieb, Scott</topic><topic>Liljenquist, Dan</topic><topic>Nonprofit organizations</topic><topic>Pharmaceutical industry</topic><topic>Prices</topic><topic>Shkreli, Martin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Roehr, Bob</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection (ProQuest)</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Research Library</collection><collection>Science Database (ProQuest)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>BMJ (Online)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Roehr, Bob</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>US hospitals launch non-profit generic drug producer to counter rising prices</atitle><jtitle>BMJ (Online)</jtitle><addtitle>BMJ</addtitle><date>2018-09-07</date><risdate>2018</risdate><volume>362</volume><spage>k3840</spage><epage>k3840</epage><pages>k3840-k3840</pages><issn>0959-8138</issn><eissn>1756-1833</eissn><abstract>Several American healthcare systems have joined forces to form a new non-profit pharmaceutical company to counter price gouging and scarcity of generic drugs by increasing their supply. Scott Gottlieb, the US Food and Drug Administration commissioner, has pledged to expedite approval of generic drug applications as one way to increase competition and supply, and to rein in prices. Civica Rx will initially work with generic manufacturers around the world but eventually hopes to increase production capacity within the US.</abstract><cop>England</cop><pub>BMJ Publishing Group LTD</pub><pmid>30194067</pmid><doi>10.1136/bmj.k3840</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0959-8138 |
| ispartof | BMJ (Online), 2018-09, Vol.362, p.k3840-k3840 |
| issn | 0959-8138 1756-1833 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2101270763 |
| source | Jstor Complete Legacy |
| subjects | Corporate profits Generic drugs Gottlieb, Scott Liljenquist, Dan Nonprofit organizations Pharmaceutical industry Prices Shkreli, Martin |
| title | US hospitals launch non-profit generic drug producer to counter rising prices |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T06%3A15%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=US%20hospitals%20launch%20non-profit%20generic%20drug%20producer%20to%20counter%20rising%20prices&rft.jtitle=BMJ%20(Online)&rft.au=Roehr,%20Bob&rft.date=2018-09-07&rft.volume=362&rft.spage=k3840&rft.epage=k3840&rft.pages=k3840-k3840&rft.issn=0959-8138&rft.eissn=1756-1833&rft_id=info:doi/10.1136/bmj.k3840&rft_dat=%3Cproquest_cross%3E2100741409%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2100741409&rft_id=info:pmid/30194067&rfr_iscdi=true |